• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm?

作者信息

Lonardo Amedeo, Nascimbeni Fabio, Ponz de Leon Maurizio

机构信息

Operating Unit of Internal Medicine, OCSAE, Modena, Italy

Operating Unit of Internal Medicine, OCSAE, Modena, Italy.

出版信息

Eur Respir J. 2017 Jun 8;49(6). doi: 10.1183/13993003.00546-2017. Print 2017 Jun.

DOI:10.1183/13993003.00546-2017
PMID:28596428
Abstract
摘要

相似文献

1
Nonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm?非酒精性脂肪性肝病与慢性阻塞性肺疾病：是时候跨越膈肌了吗？
Eur Respir J. 2017 Jun 8;49(6). doi: 10.1183/13993003.00546-2017. Print 2017 Jun.
2
Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease.非酒精性脂肪性肝病与慢性阻塞性肺疾病。
Eur Respir J. 2017 Jun 8;49(6). doi: 10.1183/13993003.01923-2016. Print 2017 Jun.
3
The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.非肥胖非糖尿病土耳其人群中胰岛素抵抗、代谢综合征与非酒精性脂肪性肝病之间的关系：一项初步研究。
Turk J Gastroenterol. 2014 Dec;25 Suppl 1:63-8. doi: 10.5152/tjg.2014.6233.
4
Nonalcoholic fatty liver disease as a multi-systemic disease.非酒精性脂肪性肝病作为一种多系统疾病。
World J Gastroenterol. 2016 Apr 28;22(16):4079-90. doi: 10.3748/wjg.v22.i16.4079.
5
Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.血清三酰甘油/高密度脂蛋白胆固醇比值与儿童和青少年颈动脉内膜中层厚度、胰岛素抵抗和非酒精性脂肪肝的关系。
Nutr Metab Cardiovasc Dis. 2014 Jul;24(7):737-43. doi: 10.1016/j.numecd.2014.01.010. Epub 2014 Jan 29.
6
Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.非酒精性脂肪性肝病：代谢综合征的前驱病变
Dig Liver Dis. 2015 Mar;47(3):181-90. doi: 10.1016/j.dld.2014.09.020. Epub 2014 Nov 18.
7
Response to 'Effect of metabolic components on incident type 2 diabetes mellitus in nonalcoholic fatty liver disease subjects'.对“代谢成分对非酒精性脂肪性肝病受试者发生2型糖尿病的影响”的回应
Liver Int. 2016 Mar;36(3):462. doi: 10.1111/liv.12976.
8
Clinical importance of the nonalcoholic fatty liver disease: a review.非酒精性脂肪性肝病的临床重要性：综述
Probl Radiac Med Radiobiol. 2013(18):277-88.
9
Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.学龄儿童非酒精性脂肪性肝病的患病率、危险因素及预测因素：埃及亚历山大市一项基于医院的研究
Arab J Gastroenterol. 2014 Jun;15(2):76-81. doi: 10.1016/j.ajg.2014.05.002. Epub 2014 Jul 10.
10
Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Ceramides.非酒精性脂肪性肝病、胰岛素抵抗与神经酰胺
N Engl J Med. 2019 Nov 7;381(19):1866-1869. doi: 10.1056/NEJMcibr1910023.

引用本文的文献

1
Immune-related diagnostic indicators and targeted therapies for COPD combined with NASH were identified and verified via WGCNA and LASSO.通过加权基因共表达网络分析（WGCNA）和套索回归（LASSO）鉴定并验证了慢性阻塞性肺疾病（COPD）合并非酒精性脂肪性肝炎（NASH）的免疫相关诊断指标和靶向治疗方法。
Front Immunol. 2025 Feb 28;16:1514422. doi: 10.3389/fimmu.2025.1514422. eCollection 2025.
2
MAFLD associated with COPD via systemic inflammation independent of aging and smoking in men.在男性中，MAFLD通过全身性炎症与慢性阻塞性肺疾病（COPD）相关，且独立于衰老和吸烟因素。
Diabetol Metab Syndr. 2022 Aug 16;14(1):115. doi: 10.1186/s13098-022-00887-w.
3
Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease.
代谢功能障碍相关脂肪性肝病比非酒精性脂肪性肝病与更严重的肺功能损害相关。
J Clin Transl Hepatol. 2022 Apr 28;10(2):230-237. doi: 10.14218/JCTH.2021.00306. Epub 2022 Jan 4.
4
Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review.新旧降糖药物治疗非酒精性脂肪性肝病：叙述性综述。
Clin Mol Hepatol. 2022 Oct;28(4):725-738. doi: 10.3350/cmh.2022.0015. Epub 2022 Mar 14.
5
Exogenous Bioactive Peptides Have a Potential Therapeutic Role in Delaying Aging in Rodent Models.外源性生物活性肽在延缓啮齿动物模型衰老方面具有潜在的治疗作用。
Int J Mol Sci. 2022 Jan 26;23(3):1421. doi: 10.3390/ijms23031421.
6
Hepatic Fibrosis Assessed Using Fibrosis-4 Index Is Predictive of All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease.使用纤维化 4 指数评估的肝纤维化可预测慢性阻塞性肺疾病患者的全因死亡率。
Int J Chron Obstruct Pulmon Dis. 2020 Apr 17;15:831-839. doi: 10.2147/COPD.S242863. eCollection 2020.
7
[Anesthesiological aspects of liver transplantation].[肝移植的麻醉学相关方面]
Anaesthesist. 2019 Jun;68(6):403-418. doi: 10.1007/s00101-019-0595-x.
8
Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study.肺功能下降与非酒精性脂肪性肝病发病风险的相关性：一项纵向队列研究。
PLoS One. 2019 Jan 23;14(1):e0208736. doi: 10.1371/journal.pone.0208736. eCollection 2019.
9
Relationship between obstructive lung disease and non-alcoholic fatty liver disease in the Korean population: Korea National Health and Nutrition Examination Survey, 2007-2010.韩国人群中阻塞性肺疾病与非酒精性脂肪性肝病的关系：2007 - 2010年韩国国民健康与营养检查调查
Int J Chron Obstruct Pulmon Dis. 2018 Aug 28;13:2603-2611. doi: 10.2147/COPD.S166902. eCollection 2018.
10
Nonalcoholic fatty liver disease: Evolving paradigms.非酒精性脂肪性肝病：不断变化的范式。
World J Gastroenterol. 2017 Sep 28;23(36):6571-6592. doi: 10.3748/wjg.v23.i36.6571.